Search form
Search
Login
Subscribe
Home
Country Intelligence
Industry Directory
Offsets / IC
Tenders
Australia
(21/week)
Haiti
(0/week)
Guyana
(0/week)
Honduras
(0/week)
Guatemala
(0/week)
View all
(21/week)
News
United States
(600/week)
Manufacturing
(427/week)
Energy
(314/week)
Technology
(448/week)
Environment
(249/week)
Events
About us
Who we are
Our People
Partners
Contact us
LinkedIn
Login
Twitter
Register
Home
News
Cancer
Apr 03, 2019
Anixa Biosciences Presents Cchek(TM) Prostate Cancer Detection Data at AACR Annual Meeting
Apr 02, 2019
BerGenBio: Preclinical Data Presented at AACR Reinforces Bemcentinib's Potential to Reverse Tumour Immunosuppression and Therapy Resistance
Apr 02, 2019
Arix Bioscience plc: Aura Completes $40 Million Series D Financing
Apr 02, 2019
ContextVision Earns Acclaim from Frost & Sullivan for Its AI-powered INIFY(TM) Prostate Cancer Screening Platform
Apr 02, 2019
On Testicular Cancer Awareness Month, Movember Foundation USA Releases New Survey and Digital Resources
Apr 02, 2019
Nad & Tad Urge Men to Get in Touch With Their Testes
Apr 02, 2019
LUNGevity Drives Change in the Lives of People Diagnosed with Lung Cancer
Apr 02, 2019
OncoSynergy Announces FDA Acceptance of IND Application for Phase I Trial of OS2966 in Patients with Recurrent Glioblastoma
Apr 01, 2019
Artios Pharma Announces Appointment of Dr. Ian Smith as Chief Medical Officer
Apr 01, 2019
BerGenBio: Bemcentinib in Combination With low-dose Chemotherapy Achieves Efficacy Endpoint in AML Patients
Apr 01, 2019
BERG Presents Novel Mechanism Underlying BPM 31510 in Glioblastoma and Identification of Prostate and Pancreatic Cancer Biomarkers at 2019 AACR Meeting
Apr 01, 2019
Inovio Completes Enrollment Ahead of Schedule In Immuno-Oncology Study for Glioblastoma (GBM) with INO-5401 in Combination with Regeneron's PD-1 Inhibitor
Apr 01, 2019
PotentiaMetrics Announces Additions to its Clinical Advisory Board with Doctors Carolyn Presley and Michael Papagikos
Apr 01, 2019
Phase 3 ADMIRAL Trial Data Show XOSPATA® (gilteritinib) Significantly Prolongs Overall Survival in Adult Patients with FLT3 Mutation-Positive Relapsed/Refractory Acute Myeloid Leukemia Compared with Salvage Chemotherapy
Apr 01, 2019
Kazia Presents Positive Cantrixil Phase I Data at AACR Conference
Apr 01, 2019
BGI Americas Launches Oseq(TM) Hereditary Cancer Panel to Power Global Drug Clinical Trials
Apr 01, 2019
Syndax Pharmaceuticals Presents Updated Phase 2 Data from ENCORE 601 Trial of Entinostat in Combination with KEYTRUDA® (pembrolizumab) at the American Association for Cancer Research 2019 Annual Meeting
Apr 01, 2019
Preclinical Data Demonstrates the Potential of QED Therapeutics' Infigratinib in Multiple FGFR+ Tumor Types
Apr 01, 2019
Arix Bioscience plc - Autolus Presents Initial AUTO1 Data at AACR
Apr 01, 2019
Sierra Reports Late-Breaking Preclinical Data for SRA737 Presented at AACR 2019
‹‹
Page 45
››
Latest News
Apr 26, 2024
Orbia Announces First Quarter 2024 Financial Results
Apr 26, 2024
Freeport-McMoRan Publishes 2023 Annual Report on Sustainability
Apr 26, 2024
SJW Group Announces First Quarter 2024 Financial Results
Apr 26, 2024
Delek Logistics Partners, LP Increases Quarterly Cash Distribution to $1.07 per Common Limited Partner Unit
Apr 26, 2024
NOV Reports First Quarter 2024 Results, Return of Capital Framework, $1 Billion Share Repurchase...
Apr 26, 2024
Sensient Declares Dividend
Apr 26, 2024
Stelco Holdings Inc. Schedules First Quarter 2024 Earnings Release and Conference Call
Apr 26, 2024
Tidewater Announces Earnings Release and Conference Call
View all News
Agenda
24
September
Hilton London Syon Park, London, UK
Defence Transformation Conference
Returning for its 8th year, Defence Transformation 2024 will feature an updated format that will address all aspects of...
17
June
France
Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024, 17 - 21 June 2024, Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024 There can be no sustainable world without peace and security. Founded in 1967, the exhibition...
21
May
Paris Marriott Rive Gauche & Conference Center
Future Artillery, 21-23 May 2024, Paris Marriott Rive Gauche & Conference Center, France
DELIVERING FIRES IN THE MULTI-DOMAIN BATTLESPACE As artillery reasserts itself as the ‘King of Battlefield’ in the wake...
View All Events